Diaceutics PLC (DXRX) - Total Liabilities

Latest as of June 2025: GBX7.18 Million GBX ≈ $873.84 USD

Based on the latest financial reports, Diaceutics PLC (DXRX) has total liabilities worth GBX7.18 Million GBX (≈ $873.84 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Diaceutics PLC generate cash to assess how effectively this company generates cash.

Diaceutics PLC - Total Liabilities Trend (2015–2024)

This chart illustrates how Diaceutics PLC's total liabilities have evolved over time, based on quarterly financial data. See Diaceutics PLC (DXRX) shareholders funds for net asset value and shareholders' equity analysis.

Diaceutics PLC Competitors by Total Liabilities

The table below lists competitors of Diaceutics PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Doric Nimrod Air Three Ltd LSE:DNA3	UK	GBX4.00 Million
Ordinary Fully Paid Deferred Settlement AU:TASDA	Australia	AU$16.98 Million
Dotdigital Group Plc LSE:DOTD	UK	GBX38.86 Million
CFI-Compagnie FonciÃ¨re Internationale PA:CFI	France	€225.00K
Bank Pembangunan Daerah Banten Tbk PT JK:BEKS	Indonesia	Rp8.10 Trillion
Usha Martin Education & Solutions Limited NSE:UMESLTD	India	Rs23.70 Million
Chinhung International Inc. Pfd. Series 2 KO:002787	Korea	₩253.44 Billion
Cambium Networks Corp NASDAQ:CMBM	USA	$178.98 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Diaceutics PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Diaceutics PLC stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Diaceutics PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Diaceutics PLC (2015–2024)

The table below shows the annual total liabilities of Diaceutics PLC from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX8.76 Million ≈ $1.07K	+57.66%
2023-12-31	GBX5.56 Million ≈ $676.25	-3.20%
2022-12-31	GBX5.74 Million ≈ $698.64	+31.58%
2021-12-31	GBX4.36 Million ≈ $530.97	+33.01%
2020-12-31	GBX3.28 Million ≈ $399.20	+46.54%
2019-12-31	GBX2.24 Million ≈ $272.42	-56.78%
2018-12-31	GBX5.18 Million ≈ $630.37	+43.37%
2017-12-31	GBX3.61 Million ≈ $439.69	+48.82%
2016-12-31	GBX2.43 Million ≈ $295.45	+106.72%
2015-12-31	GBX1.17 Million ≈ $142.92	--

About Diaceutics PLC

LSE:DXRX UK Health Information Services

Market Cap

$1.70 Million

GBX14.01 Billion GBX

Market Cap Rank

#29840 Global

#713 in UK

Share Price

GBX165.50

Change (1 day)

+0.00%

52-Week Range

GBX113.00 - GBX174.50

All Time High

GBX187.50